Journal of Heart and Lung Transplantation

Journal of Heart and Lung Transplantation Journal

Publication venue for

Can Household Income Predict Postoperative Outcomes After LVAD Implantation?. 41:S163-S163. 2022
Development and Validation of a Personalized Risk Score for Prediction of Patient-Specific Clinical Experiences with HeartMate 3 LVAD Implantation: An Analysis from the MOMENTUM 3 Trial Portfolio. 41:S23-S24. 2022
Does Open Chest After LVAD Surgery Affect Blood Transfusion Rates and PRA. 41:S487-S488. 2022
Does Patients with Higher Education Have Better Postoperative Results After LVAD Implantation?. 41:S162-S162. 2022
Outcomes of Intracorporeal Continuous, Paracorporeal Continuous, and Paracorporeal Pulsatile Ventricular Assist Devices in Pediatric Patients 10-30 kg. 41:S519-S520. 2022
Sternal Precautions After LVAD Implantation: Are We Overdoing It?. 41:S187-S188. 2022
Surgical Specialization and Standardization of Care Improves Outcomes in Mechanical Circulatory Support: A Single Center Experience. 41:S387-S388. 2022
Practice variation in the diagnosis of acute rejection among pediatric heart transplant centers: An analysis of the pediatric heart transplant society (PHTS) registry. 40:1550-1559. 2021
Resource utilization in children with paracorporeal continuous-flow ventricular assist devices. 40:478-487. 2021
Impact of Insurance and Race on Pediatric Heart Transplant Outcomes-An Analysis of the Pediatric Heart Transplant Society (PHTS) Registry. 40:S245-S246. 2021
Interpretation of AlloMap (R) in Clinically Stable Combined Heart-Kidney Transplant Recipients. 40:S215-S215. 2021
Preoperative Body Mass Index < 45 Kg/m(2) Predicts Clinical Success after Bariatric Surgery in Patients with Ventricular Assist Devices. 40:S414-S414. 2021
Ambulatory RVAD Using Dual Lumen Cannula-Single Center Experience. 39:S26-S26. 2020
Effect of aspirin dose on hemocompatibility-related outcomes with a magnetically levitated left ventricular assist device: An analysis from the MOMENTUM 3. 39:518-525. 2020
Post-Approval Experience with Fully Magnetically Levitated Continuous Flow Left Ventricular Assist Device- Single Center Experience. 39:S416-S416. 2020
Programmatic Specialization and Pathway Development Improves Outcomes in Mechanical Circulatory Support. 39:S332-S332. 2020
The Impact of Aspirin Dose on Hemocompatibility-Related Adverse Events during HeartMate 3 Support - An Analysis from the MOMENTUM 3 Trial. 39:S47-S47. 2020
When good intentions turn bad: A need for course correction. 39:5-6. 2020
Cardiac allograft vasculopathy and graft failure in pediatric heart transplant recipients after rejection with severe hemodynamic compromise. 38:277-284. 2019
Effects of a fully magnetically levitated centrifugal-flow or axial-flow left ventricular assist device on von Willebrand factor: A prospective multicenter clinical trial. 38:806-816. 2019
HeartMate 3 Surgical Implant Technique and Outcomes in the MOMENTUM 3 Trial. 38:S78-S78. 2019
MELD Score: A Predictor of Mortality for Patients Receiving RVAD after LVAD Implantation. 38:S362-S362. 2019
Safety of Mechanical Circulatory Support for Left Ventricular Non-Compaction: Single Center Experience. 38:S442-S443. 2019
Are Protocol Driven Biopsies After Steroid Cessation Necessary?. 37:S332-S332. 2018
Atrial Fibrillation Burden in Patients with Left Ventricular Assist Devices: Analysis from ICDs. 37:S129-S129. 2018
Center volume and post-transplant survival among adults with congenital heart disease. 37:1351-1360. 2018
Is Pre-Operative Colonoscopy Screening for LVAD Therapy Needed for Higher INTERMACS Profile Patients in the Current Era?. 37:S468-S469. 2018
Left ventricular assist device use in biventricular configurations: It takes two to tango. 37:1391-1393. 2018
Rehabilitating cardiac rehabilitation after heart transplantation. 37:437-438. 2018
The check list manifesto for mechanical circulatory support: Targeting anti-coagulation efficiency. 37:568-569. 2018
Hemodynamic effects of a fully magnetically levitated centrifugal-flow left ventricular assist device. 36:19-21. 2017
Report of the ISHLT Working Group on primary lung graft dysfunction Part IV: Prevention and treatment: A 2016 Consensus Group statement of the International Society for Heart and Lung Transplantation. 36:1121-1136. 2017
Use of Gene Expression Profiling Score Variability to Predict Cardiac Allograft Vasculopathy: A Single Center Experience. 36:S295-S295. 2017
Global Experience with the Heartware HVAD (R) in Pediatric Patients: A Preliminary Analysis. 35:S45-S45. 2016
Initial Experience with a Percutaneous Dual Lumen Single Cannula Strategy for Temporary Right Ventricular Assist Device Support Following Durable LVAD Therapy. 35:S323-S323. 2016
Simple Technique for Open Sternal Wound Closure after Cardiac Transplant or LVAD. 35:S286-S286. 2016
Triple Antithrombotic Therapy in Patients with Left Ventricular Assist Devices: A Single Center Experience. 35:S250-S251. 2016
Clinical Profiles and Outcomes of Cardiac Transplant Recipients Using Allomap and Cylex Immuknow Assays. 34:S295-S295. 2015
Pre Operative Administration of Vitamin K Reduces Bleeding in Continous Flow Devices. 34:S144-S145. 2015
Regional differences in use and outcomes of left ventricular assist devices: Insights from the Interagency Registry for Mechanically Assisted Circulatory Support Registry. 34:912-920. 2015
Update on Temporary Mechanical Circulatory Support for Right Ventricular Failure. 34:S112-S113. 2015
B-Type Natriuretic Peptide Profiles in the Setting of Chronic Left Ventricular Assist Device Support. 33:S236-S236. 2014
Blood Pressure Profiles of Patients with Left Ventricular Assist Devices. 33:S217-S217. 2014
Outpatient Experience with Heartware (R) Ventricular Assist Device System in Children: A Multicenter Experience. 33:S18-S19. 2014
Regional Differences in Utilization and Outcomes of Left Ventricular Assist Devices: Insights from the INTERMACS Registry. 33:S72-S73. 2014
The consummate clinician. 33. 2014
Bridge-to-Decision LVAD Support Using the Impella 5.0 Via a Right Subclavian Artery Approach. 32:S281-S281. 2013
High-intensity interval training in patients with cardiovascular diseases and heart transplantation. 32:1056-1058. 2013
Transcatheter Potts shunt: An innovative IDEA. 32:388-389. 2013
Advances in mechanical circulatory support: Year in review. 30:487-493. 2011
Analysis of Non-Cutaneous Cancer after Lung Transplantation. 30:S149-S149. 2011
Analysis of Nontuberculous Mycobacteria Infections in Lung Transplant Recipients. 29:S138-S138. 2010
Cardiopulmonary exercise testing in patients with pulmonary arterial hypertension: An evidence-based review. 29:159-173. 2010
Determinants of Time To Peak FEV1 after Lung Transplantation. 28:S107-S107. 2009
Dual Right Atrial Pacing Improves Paced Heart Rate Response in Orthotopic Heart Transplant Patients. 28:S196-S196. 2009
Effect of Etiology and Timing of Respiratory Tract Infections on Development of Bronchiolitis Obliterans Syndrome. 28:163-169. 2009
High-density Lipoprotein Cholesterol Levels and Prognosis in Advanced Heart Failure. 28:876-880. 2009
Single-institution Study Evaluating the Utility of Surveillance Bronchoscopy After Lung Transplantation. 28:14-20. 2009
Ganciclovir for cytomegalovirus: a call for indefinite prophylaxis in lung transplantation. 27:875-881. 2008

International Standard Serial Number (ISSN)

1053-2498